BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 14570746)

  • 1. Angiogenesis in endocrine tumors.
    Turner HE; Harris AL; Melmed S; Wass JA
    Endocr Rev; 2003 Oct; 24(5):600-32. PubMed ID: 14570746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
    Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
    Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
    La Rosa S; Uccella S; Finzi G; Albarello L; Sessa F; Capella C
    Hum Pathol; 2003 Jan; 34(1):18-27. PubMed ID: 12605362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis in endocrine glands: special reference to the expression of vascular endothelial growth factor.
    Katoh R
    Microsc Res Tech; 2003 Feb; 60(2):181-5. PubMed ID: 12539172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiogenesis and endocrine tumors].
    Dumortier J; Ratineau C; Roche C; Lombard-Bohas C; Chayvialle JA; Scoazec JY
    Bull Cancer; 1999 Feb; 86(2):148-53. PubMed ID: 10066945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis in normal and neoplastic pituitary tissues.
    Lloyd RV; Vidal S; Horvath E; Kovacs K; Scheithauer B
    Microsc Res Tech; 2003 Feb; 60(2):244-50. PubMed ID: 12539179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis in pituitary adenomas.
    Yamada S; Takada K
    Microsc Res Tech; 2003 Feb; 60(2):236-43. PubMed ID: 12539178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Angiogenesis and antiangiogenic cancer therapy].
    Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
    Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological and pathological angiogenesis in the endocrine system.
    Góth MI; Hubina E; Raptis S; Nagy GM; Tóth BE
    Microsc Res Tech; 2003 Jan; 60(1):98-106. PubMed ID: 12500266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Methoxyestradiol blocks estrogen-induced rat pituitary tumor growth and tumor angiogenesis: possible role of vascular endothelial growth factor.
    Banerjeei SK; Zoubine MN; Sarkar DK; Weston AP; Shah JH; Campbell DR
    Anticancer Res; 2000; 20(4):2641-5. PubMed ID: 10953337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions.
    Garcia de la Torre N; Buley I; Wass JA; Jackson DG; Turner HE
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2890-6. PubMed ID: 15181073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour.
    de la Torre NG; Buley I; Wass JA; Turner HE
    Endocr Relat Cancer; 2006 Sep; 13(3):931-44. PubMed ID: 16954441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis in neuroblastoma.
    Ribatti D; Marimpietri D; Pastorino F; Brignole C; Nico B; Vacca A; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():133-42. PubMed ID: 15650239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology of angiogenesis in tumors of the gastrointestinal tract.
    Reinmuth N; Parikh AA; Ahmad SA; Liu W; Stoeltzing O; Fan F; Takeda A; Akagi M; Ellis LM
    Microsc Res Tech; 2003 Feb; 60(2):199-207. PubMed ID: 12539174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.
    McCabe CJ; Boelaert K; Tannahill LA; Heaney AP; Stratford AL; Khaira JS; Hussain S; Sheppard MC; Franklyn JA; Gittoes NJ
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4238-44. PubMed ID: 12213878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of matrix metalloproteinase 9 in pituitary tumor behavior.
    Turner HE; Nagy Z; Esiri MM; Harris AL; Wass JA
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2931-5. PubMed ID: 10946906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
    Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
    Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.